Your browser doesn't support javascript.
loading
Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer Patient.
Fremd, Carlo; Hlevnjak, Mario; Zapatka, Marc; Zoernig, Inka; Halama, Niels; Fejzibegovic, Nino; Thewes, Verena; Lichter, Peter; Schirmacher, Peter; Kloor, Matthias; Marmé, Frederik; Schütz, Florian; Kosaloglu, Zeynep; Sinn, Hans Peter; Jäger, Dirk; Schneeweiss, Andreas.
Afiliação
  • Fremd C; National Center for Tumor Diseases, Department of Medical Oncology, University of Heidelberg, Heidelberg, Germany.
  • Hlevnjak M; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.
  • Zapatka M; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.
  • Zoernig I; National Center for Tumor Diseases, Department of Medical Oncology, University of Heidelberg, Heidelberg, Germany.
  • Halama N; National Center for Tumor Diseases, Department of Medical Oncology, University of Heidelberg, Heidelberg, Germany.
  • Fejzibegovic N; National Center for Tumor Diseases, Department of Medical Oncology, University of Heidelberg, Heidelberg, Germany.
  • Thewes V; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.
  • Lichter P; Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany.
  • Schirmacher P; Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Kloor M; Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Marmé F; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Schütz F; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Kosaloglu Z; Department of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
  • Sinn HP; Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
  • Jäger D; National Center for Tumor Diseases, Department of Medical Oncology, University of Heidelberg, Heidelberg, Germany.
  • Schneeweiss A; National Center for Tumor Diseases, Department of Medical Oncology, University of Heidelberg, Heidelberg, Germany.
Breast Care (Basel) ; 14(1): 53-59, 2019 Mar.
Article em En | MEDLINE | ID: mdl-31019444
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Breast Care (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Breast Care (Basel) Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Suíça